Suppr超能文献

新型无义 ATP2A2 基因突变致 COVID-19 感染后 Darier 病加重 1 例报告

Identification of a novel nonsense ATP2A2 gene variant in a patient with Darier's disease flare following COVID-19 infection: A case report.

机构信息

Department of Dermatology, Suining Central Hospital, Suining, Sichuan, People's Republic of China.

出版信息

Medicine (Baltimore). 2024 Mar 1;103(9):e37335. doi: 10.1097/MD.0000000000037335.

Abstract

RATIONALE

Darier disease (DD) is a rare autosomal dominant disorder that primarily manifests as hyperkeratotic papules and itching. The underlying etiology of DD is pathogenic variation in the ATP2A2 gene. However, this disease has a high penetrance but variable expressivity, indicating that patients inheriting the genotype may have different manifestations due to exogenous factors. Meanwhile, a few reports have documented that COVID-19 may be implicated in the flare of DD.

PATIENT CONCERNS

A 51-year-old man presented with keratotic papules and scaly erythematous rash on his trunk with pruritus after being infected with COVID-19. Laboratory test results were normal. Histological analysis revealed epidermal hyperkeratosis and intraepidermal lacunae containing dyskeratinized cells. Genetic analysis revealed a novel variant of ATP2A2 (c.815G>A, p.Trp272*), which was considered pathogenic in this case.

DIAGNOSES

The patient was diagnosed as having DD.

INTERVENTIONS

Oral acitretin and topical corticosteroid hormone ointments were used.

OUTCOMES

The patient achieved complete resolution of symptoms during the 3-month follow-up period.

LESSONS

We revealed the first novel ATP2A2 variant (c.815G>A, p.Trp272*) in the flare of DD following COVID-19 infection. Additionally, this pathogenic variant enriches the ATP2A2 gene mutation spectrum.

摘要

背景

Darier 病(DD)是一种罕见的常染色体显性遗传病,主要表现为角化过度性丘疹和瘙痒。DD 的根本病因是 ATP2A2 基因突变。然而,这种疾病有很高的外显率但表现度可变,这表明遗传了基因型的患者可能由于外源性因素而表现出不同的症状。同时,有一些报告记录 COVID-19 可能与 DD 的发作有关。

患者关注

一名 51 岁男性感染 COVID-19 后,出现躯干角化性丘疹和鳞屑性红斑,伴有瘙痒。实验室检查结果正常。组织学分析显示表皮过度角化和表皮内腔隙,内含角化不良细胞。基因分析显示 ATP2A2 存在一种新的变异(c.815G>A,p.Trp272*),在本例中被认为是致病性的。

诊断

患者被诊断为 DD。

干预措施

给予口服阿维 A 和外用糖皮质激素软膏。

结果

患者在 3 个月的随访期间症状完全缓解。

启示

我们揭示了 COVID-19 感染后 DD 发作中第一个新的 ATP2A2 变异(c.815G>A,p.Trp272*)。此外,该致病性变异丰富了 ATP2A2 基因突变谱。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/064c/10906587/94680c057ef3/medi-103-e37335-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验